NasdaqGM:CRVSBiotechs
A Look At Corvus Pharmaceuticals (CRVS) Valuation After Recent Share Price Swings
Corvus Pharmaceuticals stock moves after recent performance swings
Corvus Pharmaceuticals (CRVS) has been drawing fresh attention as its share price reflected sharp recent moves, including a 4.3% decline over the past day and a month return that is roughly 17.9% lower.
See our latest analysis for Corvus Pharmaceuticals.
Even with the latest 4.3% one day share price decline and a softer 30 day share price return of 17.9%, Corvus Pharmaceuticals still shows strong upward momentum, with a 90 day...